Nexgen Porous HA/TCP Uncemented Femoral and Tibial Baseplate Components
by Zimmer, Inc.
510(k) K041100
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK041100 | Date29 Oct 2004 | StatusActive |
Recalls
-
- Terminated Z-1031-2018
- Terminated Z-1048-2018
- Terminated Z-1032-2018
The LDPE bag packaging for various highly polished hip and knee implants may adhere to the highly polished surface, leaving residue or material from the LDPE bag on the implant after it is removed from the bag.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MBH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3565
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
This device is a porous-coated, hydroxyapatite/tricalcium phosphate (HA/TCP) femoral and tibial baseplate designed for uncemented fixation in total knee arthroplasty. It falls under the nomenclature for uncemented knee components, providing a biological interface for osseointegration without the use of bone cement.
The components are intended for use in orthopedic surgery settings and are supplied sterile for single-use. They are classified under FDA 510(k) clearance (K041100) as substantially equivalent to a predicate device, with no third-party labeling. Storage and handling must comply with sterile medical device protocols, and MRI safety considerations should be evaluated based on material composition.